Kilitch Drugs(I) Performance
- Today's Low
- ₹173
- Today's High
- ₹188
- 52 Week Low
- ₹117
- 52 Week High
- ₹250
- Open Price₹175
- Previous Close₹174
- Volume327,675
- 50 DMA₹155.87
- 100 DMA₹159.71
- 200 DMA₹167.30
Kilitch Drugs(I) Chart
Investment Returns
- Over 1 Month + 35.23%
- Over 3 Month + 16.66%
- Over 6 Month + 0.98%
- Over 1 Year -20.62%
Smart Investing Starts Here Start SIP with Kilitch Drugs(I) for Steady Growth!
Kilitch Drugs(I) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 21.2
- PEG Ratio
- 1.5
- Market Cap Cr
- 640
- P/B Ratio
- 2.4
- Average True Range
- 10.39
- EPS
- 8.63
- Dividend Yield
- 0
- MACD Signal
- 4.41
- RSI
- 71.28
- MFI
- 96.43
Latest Stock News Updates
Mumbai-based Kilitch Drugs Ltd plans to enter biosimilars and oral solids, including diabetic and weight-loss tablets, and is expanding its manufacturing capacity with a new facility in Khopoli, Maharashtra
- Business Today
- 1 year 2 months ago
The warning letter summarises significant violations of current good manufacturing practice regulations for finished pharmaceuticals at the Navi-Mumbai plant, which produces finished pharmaceuticals.
- NDTV Profit
- 2 years 1 month ago
- Moneycontrol
- 2 years 3 months ago
Kilitch Drugs(I) Financials
Kilitch Drugs(I) Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹160.58
- 50 Day
- ₹155.87
- 100 Day
- ₹159.71
- 200 Day
- ₹167.30
Resistance and Support
- R3 196.93
- R2 192.87
- R1 187.96
- S1 178.99
- S2 174.93
- S3 170.02
Kilitch Drugs(I) Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-05-15 | Audited Results | |
| 2026-02-11 | Quarterly Results & Bonus issue | |
| 2025-11-13 | Quarterly Results | |
| 2025-08-13 | Quarterly Results | |
| 2025-07-02 | Others | Inter-alia, to consider 1. Fund Raising by way of issue of equity shares of face value of 10/-each through Rights Issue. 2. Deployment of the proceeds of the Right Issue. 3. Other business matters. issue of equity shares of Rs. 10/- in the ratio of 2:23 @ premium of Rs. 347/-. |
About Kilitch Drugs(I)
- NSE Symbol
- KILITCH
- BSE Symbol
- 524500
- Managing Director
- Mr. Mukund P Mehta
- ISIN
- INE729D01010
Similar Stocks to Kilitch Drugs(I)
Popular Stocks
Kilitch Drugs(I) FAQs
Kilitch Drugs(I) share price is ₹183 As on 22 May, 2026 | 00:14
The Market Cap of Kilitch Drugs(I) is ₹640 Cr As on 22 May, 2026 | 00:14
The P/E ratio of Kilitch Drugs(I) is 21.2 As on 22 May, 2026 | 00:14
The PB ratio of Kilitch Drugs(I) is 2.4 As on 22 May, 2026 | 00:14
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.